X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (97) 97
index medicus (89) 89
oncology (54) 54
female (49) 49
middle aged (46) 46
aged (43) 43
adult (37) 37
breast cancer (35) 35
chemotherapy (33) 33
cancer (32) 32
randomized controlled trials as topic (28) 28
medicine, general & internal (27) 27
survival (26) 26
male (24) 24
therapy (23) 23
treatment outcome (23) 23
research (21) 21
analysis (19) 19
care and treatment (18) 18
anticoagulants - therapeutic use (17) 17
risk factors (17) 17
anticoagulants - adverse effects (16) 16
cell biology (16) 16
double-blind (16) 16
neoplasms - mortality (16) 16
breast neoplasms - pathology (15) 15
hemorrhage - chemically induced (15) 15
heparin, low-molecular-weight - therapeutic use (15) 15
cell lung-cancer (14) 14
low-molecular-weight (14) 14
randomized-trial (14) 14
retrospective studies (14) 14
aged, 80 and over (13) 13
anticoagulants - administration & dosage (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
body mass index (13) 13
breast neoplasms - drug therapy (13) 13
carcinoma (13) 13
deep-vein thrombosis (13) 13
metastasis (13) 13
prognosis (13) 13
time factors (13) 13
health aspects (12) 12
immunohistochemistry (12) 12
neoplasms - complications (12) 12
survival analysis (12) 12
heparin - adverse effects (11) 11
patients (11) 11
trastuzumab (11) 11
anticoagulants [therapeutic use] (10) 10
cancer patients (10) 10
heparin (10) 10
heparin - therapeutic use (10) 10
heparin, low-molecular-weight [therapeutic use] (10) 10
low-dose warfarin (10) 10
mortality (10) 10
neoplasms (10) 10
phase-ii trial (10) 10
physiology (10) 10
postmenopausal women (10) 10
research paper (10) 10
risk (10) 10
venous thromboembolism - drug therapy (10) 10
anticoagulants (9) 9
docetaxel (9) 9
heparin - administration & dosage (9) 9
heparin, low-molecular-weight - administration & dosage (9) 9
medicine (9) 9
pathological complete response (9) 9
prevention (9) 9
pulmonary-embolism (9) 9
venous thromboembolism (9) 9
warfarin - administration & dosage (9) 9
biomarkers, tumor - analysis (8) 8
bleeding complications (8) 8
carcinoma, small cell - mortality (8) 8
diagnosis (8) 8
disease-free survival (8) 8
drug therapy (8) 8
efficacy (8) 8
epidemiology (8) 8
expression (8) 8
heparin [therapeutic use] (8) 8
kaplan-meier estimate (8) 8
risk-factors (8) 8
secondary prevention (8) 8
surgery (8) 8
venous thrombosis - prevention & control (8) 8
vitamin k - antagonists & inhibitors (8) 8
administration, oral (7) 7
anticoagulants [administration & dosage; adverse effects] (7) 7
antineoplastic agents - therapeutic use (7) 7
breast neoplasms, male - pathology (7) 7
dna damage (7) 7
dosage and administration (7) 7
estrogen (7) 7
fasting glucose (7) 7
hemorrhage [chemically induced] (7) 7
heparin, low-molecular-weight - adverse effects (7) 7
hippo pathway (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2011, Volume 1, Issue 1, p. CD006652
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2018, Volume 2018, Issue 7, p. CD009447
Background The choice of the appropriate perioperative thromboprophylaxis for people with cancer depends on the relative benefits and harms of different... 
Hemorrhage [chemically induced] | EXTERNAL PNEUMATIC COMPRESSION | LOW-DOSE HEPARIN | Humans | Heparin [administration & dosage; adverse effects] | Neoplasms [mortality surgery] | FATAL PULMONARY-EMBOLISM | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | FACTOR-BEARING MICROPARTICLES | Post-operative Complications [mortality; prevention & control] | Randomized Controlled Trials as Topic | Thrombocytopenia [prevention & control] | Heparin, Low-Molecular-Weight [administration & dosage; adverse effects] | Thrombosis [mortality; prevention & control] | Venous Thrombosis [prevention & control] | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | Anticoagulants [administration & dosage; adverse effects] | Pulmonary Embolism [prevention & control] | POSTOPERATIVE VENOUS THROMBOEMBOLISM | MAJOR ABDOMINAL-SURGERY | UNFRACTIONATED HEPARIN | Blood Loss, Surgical - statistics & numerical data | Pulmonary Embolism - prevention & control | Anticoagulants - administration & dosage | Neoplasms - surgery | Postoperative Complications - prevention & control | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Neoplasms - mortality | Postoperative Complications - mortality | Anticoagulants - adverse effects | Blood Transfusion - statistics & numerical data | Heparin - adverse effects | Thrombocytopenia - prevention & control | Venous Thrombosis - prevention & control | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Thrombosis - prevention & control | Thrombosis - mortality
Journal Article
Frontiers in Psychology, ISSN 1664-1078, 2012, Volume 3, p. 310
Memory is prone to illusions. When people are presented with lists of words associated with a non-presented critical lure, they produce a high level of false... 
DRM paradigm | Autobiographical IAT | False memories | Implicit level | Implicit associations | PSYCHOLOGY, MULTIDISCIPLINARY | false memories | implicit associations | autobiographical IAT | implicit level | implict level
Journal Article
JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 12/2018, Volume 7, Issue 12, p. 542
Evidence has recently emerged on the influence of gender on the immune system. In this systematic review and meta-analysis of phase III randomized clinical... 
MULTICENTER | gender | nivolumab | sex | atezolizumab | MECHANISMS | immune checkpoint inhibitors | anti-PD-1 | DOCETAXEL | CHEMOTHERAPY | pembrolizumab | MEDICINE, GENERAL & INTERNAL | durvalumab | RECURRENT | ipilimumab | DOUBLE-BLIND | PDL-1 | SEX-DIFFERENCES | anti-CTLA-4 | anti-PD-1/PDL-1
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 2013, Volume 32, Issue 1, pp. 67 - 67
Journal Article
Translational Cancer Research, ISSN 2218-676X, 10/2017, Volume 6, pp. S1281 - S1284
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 28, pp. 43188 - 43198
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2008, Volume 99, Issue 12, pp. 1176 - 1180
Summary We systematically reviewed the literature to compare the relative efficacy and safety of extended versus limited duration heparin for perioperative... 
Cellular Proteolysis and Oncology | METAANALYSIS | PROLONGED THROMBOPROPHYLAXIS | PREVENTION | prophylaxis | heparins | MALIGNANCY | thrombosis | VENOUS THROMBOEMBOLISM | RECOMMENDATIONS | PERIPHERAL VASCULAR DISEASE | COMPLICATIONS | MAJOR ABDOMINAL-SURGERY | HEMATOLOGY | Cancer | surgery
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 11/2019, Volume 14, Issue 11, pp. 1924 - 1934
Introduction: Molecular characterization studies revealed recurrent kelch like ECH associated protein 1 gene (KEAP1)/nuclear factor, erythroid 2 like 2 gene... 
LANDSCAPE | KEAP1 | Lung adenocarcinoma | CANCER | Fast progressors | REPAIR | EMERGING ROLE | NRF2 | ONCOLOGY | RESPIRATORY SYSTEM | KEAP1/NFE2L2 | Stress response pathway | CHEMORESISTANCE | OUTCOMES
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 2013, Volume 32, Issue 1, p. 49
Journal Article
Journal of cellular physiology, ISSN 0021-9541, 01/2020
Body mass index (BMI) is a main indicator of obesity and its association with breast cancer is well established. However, little is known in the metastatic... 
Journal Article